other material
confidence high
sentiment neutral
materiality 0.60
Guardian Pharmacy completes $31/share synthetic secondary; loses controlled company status
Guardian Pharmacy Services, Inc.
- Company sold 1,020,000 new shares at $31 in public offering; used proceeds to buy 1,020,000 shares from holders, cancelling them; no net share change.
- Selling stockholders (Bindley Capital, Cardinal Equity, etc.) sold 5,880,000 shares; company received no proceeds from that portion.
- Selling stockholders no longer hold majority voting power; Guardian ceases to be a controlled company under NYSE rules as of March 20, 2026.
- Board established Nominating and Governance Committee with independent members Cosler, Lewis, Patchett effective March 20, 2026.
- Stock Purchase Agreements allow up to 1,833,344 share repurchases from holders; further public offerings possible until June 30, 2026.